Are polymorphisms of N-acetyltransferase genes susceptible to primary liver cancer in Luoyang, China?

World Journal of Gastroenterology

Volumn 11, Issue 10, 2005, Pages 1457-1462

  Zhang, Xiu Feng ^a   Bian, Jian Chao ^a   Zhang, Xiao Yan ^a   Zhang, Zhu Mei ^a   Jiang, Feng ^a   Wang, Qi Min ^b   Wang, Qi Jun ^b   Cao, Yan Yan ^a   Tang, Bo Ming ^b  

^a FUDAN UNIVERSITY   (China)

^b Luoyang Ctr for Dis Control/Prev   (China)

Author keywords

N acetyltransferase genes; Polymorphisms; Primary liver cancer

Indexed keywords

ACYLTRANSFERASE; GENOMIC DNA;

ALLELE; ARTICLE; BLOOD SAMPLING; CANCER INCIDENCE; CANCER RISK; CHINA; CONTROLLED STUDY; GENE AMPLIFICATION; GENE FREQUENCY; GENE IDENTIFICATION; GENE SEQUENCE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HUMAN; LIVER CANCER; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; POPULATION DISTRIBUTION; POPULATION RESEARCH; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

EID: 16344363415     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i10.1457     Document Type: Article

References (22)

1. Murray CJ, Lopez AD. Mortality by cause for eight regions of the world: Globle burden of disease study. Lancet 1997; 349: 1269-1276
2. Tang ZY. Hepatocellular carcinoma-cause, treatment and metastasis. World J Gastroenterol 2001; 7: 445-454
3. Xiao KY, Peng MH. Advances in epidemiologic study of primary liver cancer. Zhongguo Puwai Jichu Yu Linchuang Zazhi 2000; 7: 272-274
4. Hein DW. N-acetyltransferase genetics and their role in predisposition to aromatic and heterocyclic amine-induced carcinogenesis. Toxicol Lett 2000; 112-113: 349-356
5. Bian JC, Shen FM, Wang JB, Wu Y, Zhang BC. Relationship between genetic polymorphism of N-acetyltransferase and genetic susceptibility to primary hepatocellular carcinoma. Zhonghua Yixue Yichuanxue Zazhi 1997; 14: 16-20
6. Chinese Anti-Cancer Association. Diagnostic criteria for primary liver cancer. Zhonghua Ganzangbing Zazhi 2000; 8: 135
7. Deitz AC, Doll MA, Hein DW. A restriction fragment length polymorphism assay that differentiates human N-acetyltransferase-1 (NAT1) alleles. Anal Biochem 1997; 253: 219-224
8. Doll MA, Fretland AJ, Deitz AC, Hein DW. Determination of human NAT2 acetylator genotype by restriction fragment-length polymorphism and allele-specific amplification. Anal Biochem 1995; 231: 413-420
9. Hein DW, Leff MA, Ishibe N, Sinha R, Frazier HA, Doll MA, Xiao GH, Weinrich MC, Caporaso NE. Association of prostate cancer with rapid N-acetyltransferase 1 (NAT1*10) in combination with slow N-acetyltransferase 2 acetylator genotypes in a pilot case-control study. Environ Mol Mutagen 2002; 40: 161-167
10. Bian JC, Wang JB, Wu Y, Zhang BC, Shen FM. Relationship between GSTM1 null genotype and genetic susceptibility to pri-mary hepatocellular carcinoma. Zhonghua Yixue Yichuanxue Zazhi 1996; 13: 353-356
11. Hsieh FI, Pu YS, Chern HD, Hsu LI, Chiou HY, Chen CJ. Genetic polymorphisrns of N-acetyltransferase 1 and 2 and risk of cigarette smoking-related bladder cancer. Br J Cancer 1999; 81 537-541
12. Zhao B, Lee EJ, Yeoh PN, Gong NH. Detection of mutations and polymorphism of N-acetyltransferase 1 gene in Indian, Malay and Chinese populations. Pharmacogenetics 1998; 8: 299-304
13. Lee EJ, Zhao B, Seow-Choen F. Relationship between polymorphism of N-acetyltransferase gene and susceptibility to colorectal carcinoma in a Chinese population. Pharmacogenetics 1998; 8: 513-517
14. Millikan RC, Pittman GS, Newman B, Tse CK, Selmin O, Rockhill B, Savitz D, Moorman PG, Bell DA. Cigarette smoking, N-acetyltransferases 1 and 2, and breast cancer risk. Cancer Epidemiol Biomarkers Prev 1998; 7: 371-378
15. Bouchardy C, Mitrunen K, Wikman H, Husgafvel-Pursiainen K, Dayer P, Benhamou S, Hirvonen A. N-acetyltransferase NAT1 and NAT2 genotypes and lung cancer risk. Pharmacogenetics 1998; 8: 291-298
16. Katoh T, Kaneko S, Boissy R, Watson M, Ikemura K, Bell DA. A pilot study testing the association between N-acetyltransferases 1 and 2 and risk of oral squamous cell carcinoma in Japanese people. Carcinogenesis 1998; 19: 1803-1807
17. Yu MW, Pai CI, Yang SY, Hsiao TJ, Chang HC, Lin SM, Liaw YF, Chen PJ, Chen CJ. Role of N-acetyltransferase polymorphisms in hepatitis B related hepatocellular carcinoma: Impact of smoking on risk. Gut 2000; 47: 703-709
18. Ishibe N, Sinha R, Hein DW, Kulldorff M, Strickland P, Fretland AJ, Chow WH, Kadlubar FF, Lang NP, Rothman N. Genetic polymorphisms in heterocyclic amine metabolism and risk of colorectal adenomas. Pharmacogenetics 2002; 12: 145-150
19. Zheng W, Deitz AC, Campbell DR, Wen WQ, Cerhan JR, Sellers TA, Folsom AR, Hein DW. N-acetyltransferase 1 genetic polymorphism, cigarette smoking, well-done meat intake, and breast cancer risk. Cancer Epidemiol Biomarkers Prev 1999; 8: 233-239
20. Huang YS, Chern HD, Wu JC, Chao Y, Huang YH, Chang FY, Lee SD. Polymorphism of the N-acetyltransferase 2 gene, red meat intake, and the susceptibility of hepatocellular carcinoma. Am J Gastroentero 2003; 98: 1417-1422
21. Agundez JA, Olivera M, Ladero JM, Rodriguez-Lescure A. Ledesma MC, Diaz-Rubio M, Meyer UA, Benitez J. Increased risk for hepatocellular carcinoma in NAT2-slow acetylators and CYP2D6-rapid metabolizers. Pharmacogenetics 1996; 6: 501-512
22. Gao JP, Huang YD, Lin JA, Zhu QC, Liang JP. Relationship between genetic polymorphisms of N-acetyltransferase and susceptibility to hepatocellular carcinoma. Zhonghua Ganzangbing Zazhi 2003; 11: 20-22